When: $248-$252 range

Then: Sell 50% of trim allocation via TWAP over 1-3 sessions

When: $258-263 range

Then: Sell 50% of trim allocation via limit orders

TRIM: Sell 25-33% of position at $260 into resistance, preserve core exposure, redeploy on confirmed breakout above $260 or macro improvement with yields declining

• Capex funding model has shifted materially — 2024 OCF $115.9B against capex $83B (72% coverage) deteriorating to Q1 2026 OCF $26B against capex $44.2B (59% coverage), with $52.8B in net debt issued in a single quarter to plug the gap
• Forward P/E of 24.5x on $10.38 EPS is computed on trailing-inflated earnings; TTM EPS of $12.43 includes ~$15B in one-time Anthropic gains, implying normalized earnings of ~$65B and true forward P/E closer to 30x
• Sustained higher-for-longer rates with Fed cut probability only 1% through December 2026 and 50% by June 2027 creates unfavorable base case for 1.44 beta stock at stretched multiples
• Technical setup shows distribution pattern — six-week consolidation below 50-day SMA (overhead resistance), MACD below zero, RSI neutral at 48, bounce volume only 52M shares vs 90M on prior August peak (57% participation)
• Anthropic IPO offers no visibility on pricing or reception; concentration in AI capital flows creates direct hit risk to thesis if IPO prices at discount; one-time event cannot anchor recurring thesis
• Retail absence creates thin order book with no depth on bid side; August 28 gap-down (10-point decline on heavy volume) demonstrated lack of retail cushion
• Holding or adding requires simultaneous correctness on AWS re-acceleration, AI capex ROI validation, and rates not re-pricing higher — concentrated bet with no margin for error
• Disciplined trim into $260 resistance (50-day SMA, Bollinger upper band, known short-term resistance) locks in August rally gains while preserving franchise exposure

→ vs aggressive: Historical capex cycles were funded by OCF; current cycle requires $52.8B in net debt issuance, representing a fundamentally different and riskier funding model at 5% yields with 1.44 beta

→ vs aggressive: Forward P/E comparison to 5-year average is intellectually dishonest — TTM earnings inflated by ~$15B in one-time Anthropic gains, making true normalized P/E closer to 30x, not 24.5x

→ vs aggressive: Polymarket rate cut data (1% by Dec 2026, 50% by June 2027) represents a higher-for-longer base case, not asymmetric upside — building core positions on tail rate scenarios violates risk management principles

→ vs aggressive: Compressed volatility does not reliably favor primary trend continuation; six-week consolidation below 50-day SMA with 57% bounce volume is a distribution pattern until proven otherwise, not a coiled spring

→ vs aggressive: Anthropic IPO is one-time event with zero visibility on pricing/reception; cannot anchor long position around unpredictable catalyst — downside scenario equally plausible as upside

→ vs aggressive: Quiet retail is not 'under-the-radar accumulation' — it's thin order book with no depth on bid side; institutions herd on both accumulation AND distribution, creating vulnerability to rotation

Trim 15-20% of AMZN exposure, sell into strength between $258-265, hold core position through Q3 earnings and Anthropic IPO

• Trim 15-20% (not 25-33%) of AMZN exposure to manage concentration risk without abandoning core franchise
• Sell into strength between $258-265 (50 SMA / Bollinger upper band resistance cluster)
• Use mental stop at $274-278 rather than hard stop at $284 to allow the trade room to work
• Hold core position through Q3 earnings print and Anthropic IPO to preserve upside optionality
• Funding model has changed materially: Q1 2026 OCF of $26B vs capex of $44B with $52.8B net debt issuance, unlike prior cycles where capex was OCF-covered
• Normalized P/E is 28-30x on run-rate earnings (excluding Anthropic mark-up inflating TTM EPS of $12.43 vs forward EPS of $10.38)
• AWS growth at 18-quarter highs and ad revenue provide fundamental support for maintaining core exposure
• Technical setup is ambiguous: price coiling $246-$256 with 50 SMA at $255.84 overhead resistance for 6 weeks
• Bounce volume of 52M shares vs August peak of 90M signals fading participation
• Anthropic IPO is a binary catalyst that argues for reducing position size, not increasing it
• Macro uncertainty and technical uncertainty both support measured trim rather than aggressive reduction
• Primary trend structure (200 SMA rising, price above it) supports bullish interpretation equally as distribution pattern

→ vs aggressive: Historical capex cycle comparison is intellectually lazy—prior cycles had OCF covering 80-140% of capex versus current changed funding model with net debt issuance plugging $52.8B gap

→ vs aggressive: Valuation framing is misleading—trailing P/E of 20.4x includes Anthropic mark-up; normalized P/E is 28-30x, which is premium, not cheap

→ vs aggressive: Coiled spring technical argument is being read as 70/30 when tape shows 50/50; MACD below zero, bounce volume fading, and 50 SMA resistance is real

→ vs aggressive: Anthropic IPO is a binary catalyst that should REDUCE position size for long-term holders, not increase conviction

→ vs conservative: Earnings normalization bear case ignores AWS reacceleration, ad revenue growth, retail operating leverage, and AI monetization potential over 2-3 years

→ vs conservative: Rate environment is moderating, not deteriorating—base case is 'yields stay roughly here' not 'yields go higher'; 1.44 beta stock benefits from dovish surprises

→ vs conservative: Technical distribution is ONE interpretation; equally valid interpretation is consolidation after $235-$284 rally that often resolves in direction of prior trend

→ vs conservative: Anthropic is a symmetric catalyst with moderate skew both ways, not purely downside—successful IPO crystallizes value for AMZN